Safety and tolerability study of Cotadutide in Japanese obese subjects with type 2 diabetes melitus

Trial Identifier: D5671C00003
Sponsor:AstraZeneca
Collaborator:
Medimmune
NCTID:NCT04208620
Start Date:January 2020
Primary Completion Date: July 2020
Study Completion Date: July 2020
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

LanguageDescription
English Version
Japanese Translation

Trial Locations

CountryLocation
Japan Shinjuku-ku, Japan, 160-0008
Japan Shinjuku-ku, Japan, 162-0053
Japan Suita-shi, Japan, 565-0853